p53-Therapeutics, Inc.
PrivateCompany Overview
p53-Therapeutics, Inc. is a biotechnology company developing a new class of small molecule cancer therapeutics to effectively bypass mutations in the p53 tumor suppressor gene.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
p53-Therapeutics, Inc. Comparables
Compare p53-Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nutshell Therapeutics | 84% | |
| PMV Pharma | 82% | |
| Frontier Medicines | 79% |
p53-Therapeutics, Inc. Funding Rounds
Historical fundraising activity
p53-Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about p53-Therapeutics, Inc.'s valuation, stock price, and market status.
Is p53-Therapeutics, Inc. a public or private company?
p53-Therapeutics, Inc. is a private company.
What is the current stock price of p53-Therapeutics, Inc.?
p53-Therapeutics, Inc. is a private company with no public stock price. Caplight tracks p53-Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is p53-Therapeutics, Inc. worth (valuation)?
Valuation information for p53-Therapeutics, Inc. is not publicly available.
Can I buy p53-Therapeutics, Inc. stock?
p53-Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was p53-Therapeutics, Inc.'s last funding round?
Funding round information for p53-Therapeutics, Inc. is not publicly available.
Who are the main investors in p53-Therapeutics, Inc.?
Investor information for p53-Therapeutics, Inc. is not publicly disclosed.
Will p53-Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for p53-Therapeutics, Inc..
How can I track p53-Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor p53-Therapeutics, Inc.'s secondary market activity and sign up for updates.